Vol. 9, Special Issue 6, Part A (2025)

A total of 1951 dogs were screened, of which 117 were anemic, and 23 (19.66%) were diagnosed with IDA, resulting in an overall hospital prevalence of IDA as 1.18%. Clinical signs observed in IDA-affected dogs included lethargy, melena, weight loss, anorexia, and inappetence. Physical examination revealed pale mucous membranes, enlarged lymph nodes, and icteric mucous membranes. Haematological analysis confirmed microcytic hypochromic anemia, with significantly decreased haemoglobin (7.25±0.24 g/dl), PCV (21.87±0.73%), and TEC (3.60±0.13 × 10⁶/μl). Serum biochemical findings showed low iron levels (57.35±3.78 µg/dl), increased TIBC (383.20±9.25 µg/dl), and reduced%TSAT (15.06±0.98%). Etiological factors included Ancylostoma caninum, gastritis, Babesia gibsoni, demodicosis, and haematuria. The 20 IDA-positive dogs were divided into two treatment groups: Group I received allopathic therapy (iron dextran, ferrous glycinate, copper glycinate, and cobalt glycinate), and Group II received homeopathic treatment (Ferrum metallicum 30C, Cobaltum metallicum 30C, and Cuprum metallicum 30C). Both allopathic and homeopathic treatments were effective in managing IDA in dogs, with allopathy providing marginally faster iron replenishment and homeopathy offering sustained benefits. The study highlights the potential of homeopathic remedies as a viable and cost-effective alternative to synthetic iron supplementation, particularly in non-emergency cases.